American Methadone Treatment Association Opioid Treatment in the 21st Century: Implementing the Vision October 7-10, 2001 St. Louis

American Methadone Treatment Association1
Opioid Treatment in the 21st Century: Implementing the Vision
October 7-10, 2001
St. Louis

Advocacy Events and Patient Participation
NAMA at AMTA Conference 2001

Sunday, October 7th

Pre-conference Meeting 9 A.M. to 5 P.M.
Unifying the Treatment Community
Moderator Todd Rosendale, Center for Substance Abuse Treatment
Speakers

  • Fred Christie, AFFIRM (President)
  • Jo Sotheran, NAMA Board of Directors (Treasurer)
  • James DePasquale, NAMA Membership Director [Former] and Long Beach Patient Committee
  • Joycelyn Woods, NAMA Board of Directors (President)

(Sponsored by the Center for Substance Abuse Treatment)

The First Patients Advocates Illumination Award 4 P.M.
Chair Todd Rosendale, Center for Substance Abuse Treatment
Presented by Joycelyn Woods, NAMA

The Advocacy Coalition will present the first patient’s Advocates Illumination Award to an individual and/or treatment program whose persistence in the search of solutions to the myriad problems of addictive disease, has significantly improved the experience and outcome of treatment.

Presented to Dr. Marc Shinderman and the Center for Addiction Problems
(Sponsored by the Center for Substance Abuse Treatment)

Welcome Reception 6 P.M. (Conference Starts)

Monday, October 8th

Opening Address 8 A.M.

Policy Makers Luncheon 11 A.M. to 1 P.M.
Chair Mark Parrino, American Methadone Treatment Association

The Policy Maker’s Luncheon is an invitation only event that is attended by the federal and state agencies and organizational representatives (i.e. ASAM, NAMA). The luncheon was initiated as a way to get the regulatory bodies together for discussions prior to changes in the federal regulation.

(Sponsored by the American Methadone Treatment Association)

Poster Session 2 P.M 2
Hepatitis C and the Methadone Patient

Authors

  • Tony Scro, NAMA Board of Directors (Grievance Coordinator) and ABATE (President)
  • Rokki Baker, NAMA Board of Directors (Chapter Coordinator), NAMA Nor-Cal (President) and Santa Cruz Hepatitis C Task Force
  • John Finger, NAMA (Regional Director), TexNAMA (President)
  • Barbara Finger, NAMA Board of Directors (Communication’s Specialist),TexNAMA (Vice President)

NAMA Organizational Meeting 7 P.M.
Chairs
Jo Sotheran, NAMA Board of Directors (Treasurer)
Joycelyn Woods, NAMA Board of Directors (President)

Many organizations use the conference as an opportunity to meet and NAMA is no different. Twenty-six NAMA representatives from around the country met to discuss patient advocacy issues.

Tuesday, October 9th

Hot Topic Round Table 2 P.M.
Administrative Detox: Necessary Use or Abuse

Authors

  • Joe Neuberger, Delaware NAMA (President)
  • James DePasquale, NAMA Membership Director and Long Beach Patient Comittee

Award Banquet 8 P.M.

The first conference of the new millennium heralds the recognition and acceptance of patient advocacy. For the first time no less than three awards were presented to patient advocates recognizing their work.

Wednesday, October 10th

Workshop 8 A.M.
Past, Present and Future: A Selection of Unfinished Business in Methadone Treatment
Authors

  • Moderator, Howard Lotsof, NAMA Acting Membership Director
  • Gary Nessenbaum, Washington Advocates for Methadone Maintenance (President)
  • Carmen Pearman, NAMA Regional Director and The MAG of Indiana (President)
  • Jo Sotheran, NAMA Board of Directors (Treasurer)
  • James DePasquale, NAMA Membership Director and Long Beach Patient Committee
  • Joycelyn Woods, NAMA Board of Directors (President)

Press Conference 12 P.M.
Director Jeanne Henry, Office of Public Affairs, Sate of Missouri, Department of Mental Health
Patient Advocacy Interviews Organized by Norma Alexander, NAMA Media Director
Interviews

  • Joycelyn Woods, NAMA Board of Directors (President)
  • Howard Lotsof, NAMA Acting Membership Director
  • Barbara Finger, NAMA Board of Directors (Communication’s Specialist) and TexNAMA (Vice President)

Sponsored by State of Missouri, Department of Mental Health

Closing Address 12 P.M.

Smoozing Around The Conference

A quick photo album of the conference.

Notes

1. Now the American Association for the Treatment of Opioid Dependence.
2. The Hepatitis C Poster Session is only available as a PowerPoint Presentation!

Similar Posts

  • NAMA

    Admin 04/23/2021

    Telling The Untold Methadone Success Stories This Treatment Works “There may be no more effective way to contain heroin abuse than methadone, a drug that blocks an addict’s craving. Yet new efforts to expand use of methadone have inspired new attacks on it, attacks that deny common sense.“ -The New York Times, April 8, 1990…

  • NAMA Policy Statement: A Commentary on Federal Policy for Patients Receiving Over 100 mgs (Revised)

    Admin 09/23/2022

    There are many misperceptions and misunderstanding about the federal regulations and particularly when it comes to issues regarding raising the dose over 100 mgs. Prior to the HIV epidemic in order to raise a patient’s dose it was required for the physician to contact the Food and Drug Administration (FDA) for permission. In the early…

  • Author: NAMA Recovery

    Admin 06/11/2022

    Herman Joseph, PhD 1931 – 2019 May 28, 2019 May 6, 2019 Dr. Joseph was one of the important influences on addiction and criminal justice during the latter 20th and early 21st century.  For more than 50 years he has worked as a social research scientist in the interrelated fields of addiction, treatment, criminal justice,…

  • Letter to the editor

    Admin 10/26/2021

    Letter to the editor RoanokeTimes (in publication) January 3, 2005 Give some credit to methadone treatment. In response to your Dec. 19 news article, “Are drug deaths decreasing?”: I’d like to make an observation. I’m struck that in trying to find an answer as to why the “drug deaths” may be decreasing, there’s a glaring…

  • Federal Agencies

    Admin 10/16/2022

    United States Regulations Code of Federal Regulations 42 Part 8. Opioid Drugs in Maintenance and Detoxification Treatment of Opiate Addiction. Federal Register 17 January 2001. (PDF Format) Publication of Final Rule with comments. 42 Code of Federal Regulations Part 2 . Confidentiality of Alcohol and Drug Abuse Patient Records. New Take Home Regulations. Page 4098…

  • Smoozing the Conference

    Admin 12/09/2022

    The Reception 40 Years Wow It’s hard to believe… Dr. Tom Payte the Conference Chair (a CMA too) cuts the cake while Mark Parrino Director of AATOD looks on with a big smile. Walter Talks PSCEP with Yvette Torres The reception is a great place to network so Walter Ginter (Vice President) finds Yvette Torres…